+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Pharmaceuticals Market in Germany 2024-2028 - Product Thumbnail Image

Pharmaceuticals Market in Germany 2024-2028

  • Report
  • August 2024
  • 130 Pages
  • Germany
From
Cancer Biologics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cancer Biologics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 193 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 188 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Global Strategic Business Report

  • Report
  • September 2025
  • 102 Pages
  • Global
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • September 2025
  • 291 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 126 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 291 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 371 Pages
  • Global
From
Antibody Fragments - Global Strategic Business Report - Product Thumbnail Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • September 2025
  • 176 Pages
  • Global
From
Loading Indicator